Page 209 - Read Online

Zhu et al. Endoglin and cerebral vascular diseases

in correlation to the VEGF expression and microvessel density. Int J tumor endothelium. Blood 2004;104:1769-77.
Mol Med 2005;15:15-9. 56. Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR,
40. Hao Q, Zhu Y, Su H, Shen F, Yang GY, Kim H, Young WL. VEGF Al-Shahi Salman R, Vicaut E, Young WL, Houdart E, Cordonnier
+/-
induces more severe cerebrovascular dysplasia in Endoglin than in C, Stefani MA, Hartmann A, von Kummer R, Biondi A, Berkefeld
Alk1 mice. Transl Stroke Res 2010;1:197-201. J, Klijn CJ, Harkness K, Libman R, Barreau X, Moskowitz AJ;
+/-
41. Hao Q, Liu J, Pappu R, Su H, Rola R, Gabriel RA, Lee CZ, Young WL, international ARUBA investigators. Medical management with or
Yang GY. Contribution of bone marrow-derived cells associated with without interventional therapy for unruptured brain arteriovenous
brain angiogenesis is primarily through leukocytes and macrophages. malformations (ARUBA): a multicentre, non-blinded, randomised trial.
Arterioscler Thromb Vasc Biol 2008;28:2151-7. Lancet 2014;383:614-21.
42. Choi EJ, Walker EJ, Degos V, Jun K, Kuo R, Pile-Spellman J, Su H, 57. Zhu W, Shen F, Mao L, Zhan L, Kang S, Sun Z, Nelson J, Zhang R,
Young WL. Endoglin deficiency in bone marrow is sufficient to cause Zou D, McDougall CM, Lawton MT, Vu TH, Wu Z, Scaria A, Colosi
cerebrovascular dysplasia in the adult mouse after vascular endothelial P, Forsayeth J, Su H. Soluble FLT1 gene therapy alleviates brain
growth factor stimulation. Stroke 2013;44:795-8. arteriovenous malformation severity. Stroke 2017;48:1420-3.
43. Kim H, Pawlikowska L, Chen Y, Su H, Yang GY, Young WL. Brain 58. Guo B, Kumar S, Li C, Slevin M, Kumar P. CD105 (endoglin),
arteriovenous malformation biology relevant to hemorrhage and apoptosis, and stroke. Stroke 2004;35:e94-5.
implication for therapeutic development. Stroke 2009;40:S95-7. 59. Lastres P, Letamendia A, Zhang H, Rius C, Almendro N, Raab U, Lopez
44. Letteboer TG, Benzinou M, Merrick CB, Quigley DA, Zhau K, Kim IJ, LA, Langa C, Fabra A, Letarte M, Bernabeu C. Endoglin modulates
To MD, Jablons DM, van Amstel JK, Westermann CJ, Giraud S, Dupuis- cellular responses to TGF-beta 1. J Cell Biol 1996;133:1109-21.
Girod S, Lesca G, Berg JH, Balmain A, Akhurst RJ. Genetic variation 60. Pepper MS. Transforming growth factor-beta: vasculogenesis,
in the functional ENG allele inherited from the non-affected parent angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev
associates with presence of pulmonary arteriovenous malformation in 1997;8:21-43.
hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence 61. Pollman MJ, Naumovski L, Gibbons GH. Vascular cell apoptosis: cell type-
expression of PTPN14. Front Genet 2015;6:67. specific modulation by transforming growth factor-beta1 in endothelial
45. Allinson KR, Carvalho RL, van den Brink S, Mummery CL, Arthur cells versus smooth muscle cells. Circulation 1999;99:2019-26.
HM. Generation of a floxed allele of the mouse Endoglin gene. Genesis 62. Boche D, Cunningham C, Gauldie J, Perry VH. Transforming growth
2007;45:391-5. factor-beta 1-mediated neuroprotection against excitotoxic injury in
46. Choi EJ, Walker EJ, Shen F, Oh SP, Arthur HM, Young WL, Su vivo. J Cereb Blood Flow Metab 2003;23:1174-82.
H. Minimal homozygous endothelial deletion of Eng with VEGF 63. Buisson A, Lesne S, Docagne F, Ali C, Nicole O, MacKenzie ET, Vivien
stimulation is sufficient to cause cerebrovascular dysplasia in the adult D. Transforming growth factor-beta and ischemic brain injury. Cell Mol
mouse. Cerebrovasc Dis 2012;33:540-7. Neurobiol 2003;23:539-50.
47. Choi EJ, Chen W, Jun K, Arthur HM, Young WL, Su H. Novel brain 64. Sanchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabeu C.
arteriovenous malformation mouse models for type 1 hereditary Endoglin expression is regulated by transcriptional cooperation between
hemorrhagic telangiectasia. PLoS One 2014;9:e88511. the hypoxia and transforming growth factor-beta pathways. J Biol Chem
48. Post S, Smits AM, van den Broek AJ, Sluijter JP, Hoefer IE, Janssen BJ, 2002;277:43799-808.
Snijder RJ, Mager JJ, Pasterkamp G, Mummery CL, Doevendans PA, 65. Hennemann B, Ickenstein G, Sauerbruch S, Luecke K, Haas S, Horn
Goumans MJ. Impaired recruitment of HHT-1 mononuclear cells to the M, Andreesen R, Bogdahn U, Winkler J. Mobilization of CD34+
ischaemic heart is due to an altered CXCR4/CD26 balance. Cardiovasc hematopoietic cells, colony-forming cells and long-term culture-
Res 2010;85:494-502. initiating cells into the peripheral blood of patients with an acute cerebral
49. Dingenouts CK, Goumans MJ, Bakker W. Mononuclear cells and ischemic insult. Cytotherapy 2008;10:303-11.
vascular repair in HHT. Front Genet 2015;6:114. 66. Dunac A, Frelin C, Popolo-Blondeau M, Chatel M, Mahagne MH,
50. Shen F, Degos V, Chu PL, Han Z, Westbroek EM, Choi EJ, Marchuk D, Philip PJ. Neurological and functional recovery in human stroke are
Kim H, Lawton MT, Maze M, Young WL, Su H. Endoglin deficiency associated with peripheral blood CD34+ cell mobilization. J Neurol
impairs stroke recovery. Stroke 2014;45:2101-6. 2007;254:327-32.
51. Zhang R, Han Z, Degos V, Shen F, Choi EJ, Sun Z, Kang S, Wong M, 67. Yip HK, Chang LT, Chang WN, Lu CH, Liou CW, Lan MY, Liu JS, Youssef
Zhu W, Zhan L, Arthur HM, Oh SP, Faughnan ME, Su H. Persistent AA, Chang HW. Level and value of circulating endothelial progenitor cells
infiltration and pro-inflammatory differentiation of monocytes cause in patients after acute ischemic stroke. Stroke 2008;39:69-74.
unresolved inflammation in brain arteriovenous malformation. 68. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts
Angiogenesis 2016;19:451-61. no more. Trends Cell Biol 2009;19:43-51.
52. Milton I, Ouyang D, Allen CJ, Yanasak NE, Gossage JR, Alleyne 69. Kim SJ, Moon GJ, Cho YH, Kang HY, Hyung NK, Kim D, Lee JH,
CH Jr, Seki T. Age-dependent lethality in novel transgenic mouse Nam JY, Bang OY. Circulating mesenchymal stem cells microparticles
models of central nervous system arteriovenous malformations. Stroke in patients with cerebrovascular disease. PLoS One 2012;7:e37036.
2012;43:1432-5. 70. Simak J, Gelderman MP, Yu H, Wright V, Baird AE. Circulating
53. Shen Z, Li C, Frieler RA, Gerasimova AS, Lee SJ, Wu J, Wang MM, endothelial microparticles in acute ischemic stroke: a link to severity,
Lumeng CN, Brosius FC 3rd, Duan SZ, Mortensen RM. Smooth muscle lesion volume and outcome. J Thromb Haemost 2006;4:1296-302.
protein 22 alpha-Cre is expressed in myeloid cells in mice. Biochem 71. Ergul A, Alhusban A, Fagan SC. Angiogenesis: a harmonized target for
Biophys Res Commun 2012;422:639-42. recovery after stroke. Stroke 2012;43:2270-4.
54. Garrido-Martin EM, Nguyen HL, Cunningham TA, Choe SW, Jiang 72. Dziewulska D, Rafalowska J. Role of endoglin and transforming growth
Z, Arthur HM, Lee YJ, Oh SP. Common and distinctive pathogenetic factor-beta in progressive white matter damage after an ischemic stroke.
features of arteriovenous malformations in hereditary hemorrhagic Neuropathology 2006;26:298-306.
telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal 73. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the
models--brief report. Arterioscler Thromb Vasc Biol 2014;34:2232-6. blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and
55. Gothert JR, Gustin SE, van Eekelen JA, Schmidt U, Hall MA, Jane dementia? Stroke 2003;34:806-12.
SM, Green AR, Gottgens B, Izon DJ, Begley CG. Genetically tagging 74. Slevin M, Krupinski J, Kumar P, Gaffney J, Kumar S. Gene activation
endothelial cells in vivo: bone marrow-derived cells do not contribute to and protein expression following ischaemic stroke: strategies towards
Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ October 17, 2017 209